By Andrew Dillon2021-02-09T11:15:00
The relationship between the life sciences industry and its health system partners is sub optimal because the ambitions, constraints and risk appetites of the organisations involved in it are not sufficiently aligned. Change is needed to ensure that innovative new technologies get to patients quickly, argue Andrew Dillon and colleagues
Certain articles and Insight pieces remain paying-subscriber only content
As a registered user you will get access to:
Already registered to HSJ? Sign in now
Part of HSJ Information Ltd. 5th Floor, Aldgate Tower, 2 Leman Street, London E1 8FA. Registered in England and Wales. Company registration 2530185
Site powered by Webvision Cloud